~~<i id='59F202905F'><strike id='59F202905F'><tt id='59F202905F'><pre id='59F202905F'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

Wikipedia

comprehensive

author：explore 2025-08-06 04:47:34 - browse：56

A European regulatory panel has recommended against approval of a lung cancer drug made by Mirati Therapeutics, the company said Friday.

Mirati said it will appeal the negative opinion of the drug, called Krazati, issued by a committee of the European Medicines Agency that met this week. But for now, the adverse decision is likely to be adopted by European regulators and prevent the company from marketing the pill in Europe.

Krazati works by blocking a specific type of KRAS alteration called G12C, found in approximately 13% of lung tumors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： Prior authorization will have to move faster under new Biden rule

Wikipedia

focus

explore

leisure time

AdobeYoudidn’tneedmachinelearningtomakeonepredictionabouttheyear’sbiggestconferenceforhealthcareinve

WSS

Dramatic video released of Russian fighter jets 'harassing' US drones over Syria

Following judge's order, DOJ releases slightly less

Dewpoint Therapeutics lays off staff after losing partnerships

My yearlong odyssey to get my son’s ADHD medication covered

Eli Lilly, Pfizer, and others want in on the online prescription market

eGenesis tests gene

Wikipedia

comprehensive

Wikipedia

Moonlake's readout produced a cash windfall. Risks remain

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

Dobbs anniversary: the lost opportunity of abortion as health care

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

Virginia high school admissions case could be legal follow

Francis Collins on trust in science and how Covid communications failed

Tori Bowie and the unacceptable rates of Black maternal death

EU moves toward latest gene techniques in food production to counter climate change, shortages

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Israel withdraws forces after 2

focus

Parkinson’s finding may lead to tests and, someday, treatments

Independent physicians launch a new lobbying group

Princess Kate attends Wimbledon with Roger Federer: See the photos

AI generated plenty of interest at JPM but not a lot of trust

Readout Newsletter: BridgeBio, Madrigal, and Silicon Valley Bank

FDA clears AI tool for detecting skin cancer

focus

explore

leisure time

leisure time